66 min listen
PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine
PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine
ratings:
Length:
87 minutes
Released:
Jun 14, 2022
Format:
Podcast episode
Description
In this episode, David interviews Founder and Executive Director of MAPS, Rick Doblin, Ph.D. He discusses the abuse allegations unearthed in the recent “Cover Story” podcast series, real-world evidence, and MAPS' future goals. www.psychedelicstoday.com
Released:
Jun 14, 2022
Format:
Podcast episode
Titles in the series (100)
Daniel McQueen - Extended-State DMT Research (DMTx): Daniel McQueen - Extended-State DMT Research (DMTx) by Psychedelics Today